Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus

NCT05846347 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

CAR-T

Interventions

DRUG: GC012F injection

Sponsor

Zhejiang University

Collaborators

[object Object]